What question did this study set out to answer?

This research aims to explore the connection between semaglutide use and outcomes related to thyroid eye disease in individuals with autoimmune thyroiditis and type II diabetes.

February 2, 20261 citations

View Full Paper

Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes.

TSTehila ShlomovHebrew University of Jerusalem INItay NitzanHebrew University of Jerusalem RPRena PollackHebrew University of Jerusalem

Key Points

This research aims to explore the connection between semaglutide use and outcomes related to thyroid eye disease in individuals with autoimmune thyroiditis and type II diabetes.
Longitudinal analysis over 5 years
Assessment of TED-related diagnoses
Evaluation of TED-related treatments
Fewer TED-related diagnoses associated with semaglutide use
Reduced treatments for TED in the same population
Indicates potential protective role of semaglutide

Abstract

Semaglutide use was associated with fewer TED-related diagnoses and treatments over 5 years, supporting a potential protective role. Further studies are warranted to confirm these associations and clarify underlying mechanisms.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider